Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy.

Pulmonary arterial hypertension (PAH) is a progressive and debilitating condition. Despite promoting vasodilation, current drugs have a therapeutic window within which they are limited by systemic side effects. Nanomedicine uses nanoparticles to improve drug delivery and/or reduce side effects.

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease which continues to carry an unacceptably high mortality and morbidity. The nitric oxide (NO) pathway has been implicated in the pathophysiology and progression of the disease. Its extremely short half-life and systemic effects have hampered the clinical use of NO in PAH.

Platinum(II) complexes of N^C^N-coordinating 1,3-bis(2-pyridyl)benzene ligands: thiolate coligands lead to strong red luminescence from charge-transfer states.

A new family of platinum(II) complexes of the form PtL(n)SR have been prepared, where L(n) represents a cyclometalating, N^C^N-bound tridentate ligand and SR is a monodentate thiolate ligand. The complexes fall into two groups, those of PtL(1)SR where HL(1) = 1,3-bis(2-pyridyl)benzene, and those of PtL(2)SR, where HL(2) = methyl 3,5-bis(2-pyridyl)benzoate. Each group consists of five complexes, where R = CH3, C6H5, p-C6H4-CH3, p-C6H4-OMe, p-C6H4-NO2.

An unprecedented cyclometallated platinum(II) complex incorporating a phosphinine co-ligand: synthesis and photoluminescence behaviour.

The first luminescent cyclometallated platinum(II) complex bearing phosphinine co-ligands is reported. The long-lived luminescence, which it displays at 77 K, is assigned to a phosphinine-localised triplet excited state on the basis of electrochemical data and TD-DFT calculations.

Phosphorescent, liquid-crystalline complexes of platinum(II): influence of the β-diketonate co-ligand on mesomorphism and emission properties.

Two series of rod-like ortho-platinated complexes bound to a range of β-diketonate co-ligands are reported of the form [Pt(N^C)(O^O)]. The liquid crystal and luminescent properties are influenced through the introduction of different β-diketonates (O^O) as well as through the presence of a fused cyclopentene ring on the N^C-coordinated 2-phenylpyridine ligand. For metal complexes, smectic phases are dominant but no mesomorphism is exhibited when the β-diketonate is hexafluorinated acetylacetonate (1,1,1-5,5,5-hexafluoro-2,4-pentandione).

Aqueous methods for the preparation of 5'-substituted guanosine derivatives.

We have developed simple, aqueous strategies, that avoid the use of protecting groups and chromatography, for the preparation of a series of 5'-substituted guanosine derivatives.